This June 21-24 kicks off the joint meetings of the 16th International Congress of Endocrinology (ICE) and The Endocrine Society's (ES) 96th Annual Meeting & Expo. Of note, this joint meeting held in Chicago (McCormick Place Convention Center) will be the world's largest gathering of scientists and endocrinologists working in the field of hormone research, including those focused on the intersection of hormones and cancer.
Launched in 2009, Hormones and Cancer is a relatively new addition to The Endocrine Society's list of esteemed publications (http://press.endocrine.org/). However, the topic has long been integrated as a mainstay of annual ES programming. The 2014 ICE/ENDO program includes numerous symposia that touch on the theme of hormones and cancer, including the emerging role of extranuclear signaling actions of steroid hormones and their receptors (featured herein for estrogen receptors in a new review article from Dr. Ellis R. Levin (UC Irvine)) entitled "Translating ExtraNuclear Steroid Receptor Signaling to Clinical Medicine". Steroid hormone receptors are now well known to traffic to the plasma membrane, where they modulate signal transduction important for cellular homeostasis and gene regulation. Most recently, their role in mitochondrial function and metabolism is being investigated. These functions clearly impact cancer and as such, are potential targets for therapeutic intervention. 
